As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >


Business incubator Genopole Entreprises – 4, rue Pierre Fontaine
Téléphone : +20 1 122 998 088
Email :

Mahmoud Eljendy : Président directeur général
Web Site >
Proteinea - Genopole's company Proteinea - Genopole's company

Booster#Industrial Biotech #Biomanufacturing / Pharmaceutical Services

  • Recombinant protein production
  • Next-gen bio manufacturing platform
  • Synthetic biology
  • Metabolic engineering
  • Bioproduction
  • Bio-sourced molecules
  • Bioeconomics / Sustainable development

Field of Activity

Production as a service (PaaS) platform capable of producing recombinant proteins & enzymes cheaper and on a scale


Proteinea is an insect-based biotechnology startup. Proteinea defines the economics of building with biology by offering a one-step process to produce high-quality recombinant proteins of interest in an affordable, environmentally sustainable, and predictable manner.

Description of the Products / Services / Technology

Proteinea is integrating biology with engineering and molecular sciences to build the next-gen bio-manufacturing platform. Proteinea has developed a patent-pending technology, called InsectaPro, for using insects as mini-bioreactors to produce recombinant proteins on a scale at a significantly lower cost. It’s robust, scalable, and significantly more advantageous than conventional bioreactors.

Proteinea has a production as a service model (PaaS), in which the company secures partnerships with companies to sustainably produce (biobased and biodegradable) proteins/enzymes of interest in order to significantly reduce their environmental impact and produce at a large-scale and competitive cost coupled with high quality.

Customer references / Collaborations / Highlights

Proteinea joined IndieBio, the largest biotech accelerator, in during the winter/spring 2021 cohort.

Collaborations Sought

One of the areas Proteinea is aiming to collaborate is in the vaccine production field.

  • Further information

    4 Patents

    15 Staff members

    Proteinea is offering a one-step process to produce high-quality recombinant proteins of interest in an affordable, environmentally sustainable, and predictable manner.

    Innovation Assets:
    Using insects as mini-bioreactors to produce recombinant proteins on a scale at a significantly lower cost.


Genopole’s Companies

#Industrial Biotech

In same field

The VERY Food Co

Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.

Standing Ovation - Entreprise génopolitaine


Standing Ovation is developing the production of casein via precision fermentation to enable non-animal-derived cheese and milk substitutes.

STH Biotech - Genopole's company

STH Biotech

STH BIOTECH is developing an innovative cannabis-based process for the reliable and sustainable production of active compounds for the well-being and healthcare sectors.

Synovance - entreprise généopolitaine


Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

FABMID - entreprise génopolitaine


We develop an in vitro manufactured targeted DNA vector to improve the efficiency of therapeutic cell transfection and to reduce the cost of gene-based therapies.

Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks


Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Yposkesi - Genopole's Company


YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Watchfrog Laboratory - Genopole's company


WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Pharming - Genopole's company - Logo 2021


Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Glowee - Genopole's company


Glowee is a cleantech startup developing a disruptive lighting technology based on bioluminescence (the natural light-producing property of certain living organisms).

Global Bioenergies - entreprise génopolitaine - logo 2022

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

View all >
With the support from
Région île de France